Certain medications may interact with your current prescription medications, medical conditions, or other supplements
Our results only show the OS level at the moment the sample was taken
Intravenous administration of lipoic acid at doses of 600 mg/day for three weeks (112) and oral lipoic acid at doses as high as 1,800 mg/day for six months (113) and 1,200 mg/day for two years (76) did not result in serious adverse effects when used to treat diabetic peripheral neuropathy
Clinical Benefits: Supports cellular energy production via the Krebs cycle and mitochondrial function Assists in the metabolism of carbohydrates, fats, and proteins Supports peripheral and central nervous system function Provides antioxidant protection against oxidative stress Supports immune function and recovery from illness May help address fatigue, low mood, and cognitive difficulties This combination is often recommended as part of a broader treatment plan for patients with chronic fatigue, nutritional deficiencies, or those who are not responding adequately to oral supplementation alone
The slower absorption profile of subcutaneous delivery suits BPC-157's mechanism: as a tissue-signaling peptide, it benefits from sustained presence in circulation rather than rapid spikes
Documentation shows patients have administered 5-20 times their prescribed dose